HMGCR and aneurysm: It has been documented that HMG-CoA reductase inhibitors, also known as statins, inhibit the synthesis of cholesterol in the liver and can decrease arterial aneurysm growth rates by stabilizing endothelial function [14,15,16] and reducing inflammation and oxidative stress [17,18].